EUSEBI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 4.691
EU - Europa 3.595
AS - Asia 3.147
SA - Sud America 499
Continente sconosciuto - Info sul continente non disponibili 343
AF - Africa 80
OC - Oceania 6
Totale 12.361
Nazione #
US - Stati Uniti d'America 4.563
SG - Singapore 1.473
IT - Italia 1.304
IE - Irlanda 554
CN - Cina 472
BR - Brasile 389
HK - Hong Kong 373
RU - Federazione Russa 360
VN - Vietnam 352
FR - Francia 261
DE - Germania 237
UA - Ucraina 195
FI - Finlandia 136
GB - Regno Unito 112
SE - Svezia 102
IN - India 99
NL - Olanda 80
BD - Bangladesh 56
CA - Canada 56
KR - Corea 55
TR - Turchia 50
IQ - Iraq 45
RO - Romania 41
AR - Argentina 38
MX - Messico 37
PL - Polonia 36
JP - Giappone 34
ES - Italia 30
AT - Austria 29
ZA - Sudafrica 27
CH - Svizzera 26
CZ - Repubblica Ceca 23
PK - Pakistan 20
VE - Venezuela 18
CO - Colombia 17
UZ - Uzbekistan 17
BE - Belgio 15
ID - Indonesia 15
LT - Lituania 15
CL - Cile 12
JO - Giordania 11
SA - Arabia Saudita 11
EC - Ecuador 9
GR - Grecia 9
JM - Giamaica 9
MA - Marocco 9
DZ - Algeria 8
AL - Albania 7
PH - Filippine 7
TN - Tunisia 7
KE - Kenya 6
KG - Kirghizistan 6
PY - Paraguay 6
AU - Australia 5
AZ - Azerbaigian 5
ET - Etiopia 5
LB - Libano 5
NI - Nicaragua 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
CI - Costa d'Avorio 4
EG - Egitto 4
HN - Honduras 4
IL - Israele 4
MY - Malesia 4
NP - Nepal 4
OM - Oman 4
SI - Slovenia 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CR - Costa Rica 3
DK - Danimarca 3
HR - Croazia 3
PA - Panama 3
SN - Senegal 3
BH - Bahrain 2
BO - Bolivia 2
EU - Europa 2
GA - Gabon 2
HU - Ungheria 2
KW - Kuwait 2
KZ - Kazakistan 2
PE - Perù 2
PR - Porto Rico 2
SV - El Salvador 2
TJ - Tagikistan 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
GT - Guatemala 1
Totale 12.003
Città #
Singapore 1.089
Chandler 650
Dublin 554
San Jose 416
Hong Kong 367
Ashburn 325
Perugia 302
San Mateo 258
Boardman 182
Santa Clara 166
Moscow 138
Altamura 135
Beijing 133
Wilmington 129
Dong Ket 121
Medford 113
Princeton 112
Lauterbourg 103
Munich 97
Lawrence 95
Jacksonville 91
Los Angeles 87
Des Moines 80
Ho Chi Minh City 78
Milan 74
Andover 69
New York 63
Rome 62
Hanoi 56
The Dalles 56
Seoul 55
Ann Arbor 47
Helsinki 41
São Paulo 38
Turku 35
Dallas 34
Frankfurt am Main 32
Bucharest 30
Atlanta 29
Houston 29
Orem 27
Tokyo 27
Chennai 25
Bologna 24
Brooklyn 24
Chicago 23
Denver 23
Norwalk 23
Phoenix 23
Poplar 23
Saint Petersburg 23
Izmir 22
Nuremberg 22
Piscataway 21
Salerno 21
Council Bluffs 20
Warsaw 20
Falls Church 19
Montreal 19
Baghdad 18
Genoa 18
Mexico City 18
Amsterdam 17
Brussels 15
London 15
Modena 15
Seattle 15
Stockholm 15
Verona 15
Brno 14
Falkenstein 14
Haiphong 14
Johannesburg 14
Redwood City 14
Vienna 14
Boston 13
San Paolo di Civitate 13
Shanghai 13
Turin 13
Ankara 12
Dearborn 12
Manchester 12
Naples 12
Amman 11
Buffalo 11
San Francisco 11
Florence 10
Hefei 10
New Delhi 10
Saint Louis 10
Tashkent 10
Toronto 10
Columbus 9
Kingston 9
Lausanne 9
Mumbai 9
Padova 9
Rio de Janeiro 9
Belo Horizonte 8
Caracas 8
Totale 7.508
Nome #
The validation of an Italian version of the Freezing of Gait Questionnaire 836
CSF and blood biomarkers for Parkinson's disease 204
Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study 165
A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria data-value project 163
Accuracy of ICD-9 codes in identifying patients with peptic ulcer and gastrointestinal hemorrhage in the regional healthcare administrative database of Umbria 150
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 147
Disturbi del comportamento alimentare nei maschi: l'importanza della distorsione dell'immagine corporea. 146
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 141
Interatrial Shunting Through an Asymptomatic Patent Foramen Ovale in Thoracic Surgery 140
Validating malignant melanoma ICD-9-CM codes in Umbria, ASL Napoli 3 Sud and Friuli Venezia Giulia administrative healthcare databases: a diagnostic accuracy study 138
Brain arteriovenous malformations and seizures: an Italian study. 138
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 134
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 133
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 132
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 128
A magnetization transfer study of mild and advanced Parkinson's disease. 126
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 125
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 125
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 124
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 123
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 121
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 121
Dural arteriovenous fistulas and headache features: an observational study 121
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 120
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 120
Validity of cerebrovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project 120
Multilevel Latent Class Models for evaluation of long term care facilities 118
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 117
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 116
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 116
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 114
Occipital arteriovenous malformations andmigraine. 114
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 114
Reliability and validity of the Italian versions of the Children's Fear Survey Schedule Dental Subscale and the Modified Child Dental Anxiety Scale 114
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 113
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 112
The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: results at 1-year follow-up 112
Health technology disinvestment worldwide: Overview of programs and possible determinants 111
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 111
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 111
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 110
Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia. 109
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 109
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice 109
Applicazione della Scala Sulla Qualita della vita nelle residenze protette dell'Umbria 108
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 107
The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly 107
Oral health knowledge level of nursing staff working in semi-intensive heart failure units 107
Stima della non autosufficienza negli anziani in Umbria 106
Prevalence and risk of progression of preclinical Alzheimer's disease stages: A systematic review and meta-analysis 106
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 106
Lysosomal enzyme activities in human brain 105
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 105
Association between migraine and headache attributed to stroke: a case-control study. 104
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment 103
Distorsione dell'immagine corporea nei DCA nei maschi 102
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 102
Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts 102
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 101
Novel noninvasive biomarkers of prodromal Alzheimer disease: The role of optical coherence tomography and optical coherence tomography–angiography 101
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 100
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events 100
Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy 100
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine 99
Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease 99
New pathological findings in an international cohort of hereditary spastic paraplegia 4 patients. 98
Protocol for validating cardiovascular and cerebrovascular ICD-9-CM codes in healthcare administrative databases: The Umbria Data Value Project 96
Cerebrospinal fluid and serum D-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease 96
A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews 94
Underrecognition and undertreatment of dementia in Italian nursing homes. 92
Obsessive-compulsive disorder and migraine with medication-overuse headache. 91
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 88
Early management of patients with medication-overuse headache: results from a multicentre clinical study 88
Diagnostic utility of CSF α-synuclein species in Parkinson's disease: Protocol for a systematic review and meta-analysis 87
Stopping onabotulinum treatment after the first two cycles might not be justified: Results of a real-life monocentric prospective study in chronic migraine 87
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker 87
Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment 86
Parkinson's and Lewy body dementia CSF biomarkers 86
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 85
Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases 85
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 84
Misure relative all'obiettivo di salute numero uno del PSR 2003-2005: aspettativa di vita con e senza disabilità nella popolazione umbra. Anni 1999-2000 e 2004-2005 83
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study 83
Drug-dependence behaviour and outcome of medication-overuse headache after treatment 82
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 82
The possible role of Optical Coherence Tomography (OCT) and OCT‐Angiography (OCTA) as new non‐invasive biomarkers of prodromal Alzheimer’s disease 82
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 80
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 80
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression 80
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 80
Degradation of endocannabinoids in chronic migraine and medication overuse headache. 79
Le condizioni di salute della popolazione anziana 78
Condizioni di salute della popolazione anziana in Umbria negli anni 2004-2005 78
Subclinical vestibular dysfunction in migraineurs without vertigo: A Clinical study 78
Multilevel Latent Class Models for evaluation of long term care facilities 77
Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's Diseases 77
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease 77
Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events? 77
Stima della non autosufficienza negli anziani in Umbria 75
Hyposmia correlates with axial signs and gait disorder in Parkinson's disease: an Italian Olfactory Identification Test study 73
Totale 11.372
Categoria #
all - tutte 53.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.289


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.056 0 189 10 26 39 15 17 279 42 74 197 168
2022/20232.007 123 392 27 173 131 246 6 94 712 5 58 40
2023/2024884 40 82 39 28 18 21 197 38 42 42 150 187
2024/20252.038 48 142 82 132 211 151 111 179 369 124 318 171
2025/20264.414 274 279 245 544 654 410 661 251 542 371 111 72
2026/2027293 122 171 0 0 0 0 0 0 0 0 0 0
Totale 12.361